Leukemic stem cells and blasts isolated from AML patients release elevated levels of IL-1β and IL-6 in vitro, generating a supportive feedback loop able to maintain the proliferative capacity in vitro in the absence of the common exogenous cytokines and growth factor cocktails normally employed to stimulate cell expansion. This evidence concerns the gene IL1B and acute myeloid leukemia.